Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0532-2025Class II

(1) Medline Open Heart CDS, REF CDS840132O, packaged 1 kit/case, non-sterile; and (2) Medline Dr. Davies CV...

MEDLINE INDUSTRIES, LP - Northfield / initiated 2024-10-15 / Open, Classified / root cause: packaging

MEDLINE INDUSTRIES, LP - Northfield began a recall of (1) Medline Open Heart CDS, REF CDS840132O, packaged 1 kit/case, non-sterile; and (2) Medline Dr. Davies CV, REF DYNJ903016G, packaged 1 kit/case, non-sterile on . FDA classified it as Class II and gives the reason as "Some of the suture packages within the convenience kits contain the incorrect needle type/size and suture diameter/length". As of , the recall status on record is Open, Classified, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-0532-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Product
(1) Medline Open Heart CDS, REF CDS840132O, packaged 1 kit/case, non-sterile; and (2) Medline Dr. Davies CV, REF DYNJ903016G, packaged 1 kit/case, non-sterile.
Product code
OEZ Cardiovascular Procedure Kit
Reason for recall
Some of the suture packages within the convenience kits contain the incorrect needle type/size and suture diameter/length.
Root cause tag
packaging
FDA root cause
Mixed-up of materials/components
Action
The recalling firm issued letters on and dated 10/15/2024 via email and first-class mail explaining the issue, potential risk, and informing the consignee stickers are to be provided upon request to be placed onto the Medline pack instructing that the affected component is to be removed and replaced with an item in inventory. Required actions were included which were to (1) Immediately check your stock for the affected item number and the affected lot numbers which can be located within the recall portal. Quarantine all affected product immediately; (2) Use the link and information in the letter to complete the response form. List the quantity of affected product in inventory on the form. Upon receipt of the submitted response form, the consignee will receive over-labels to place on affected inventory with instructions for the consignee staff to remove the affected component prior to using the kit. The labels will be provided via FedEx overnight; (4) If the consignee is a distributor or has resold or transferred this product to another company or individual, the consignee is to notify them of the recall communication.
Quantity in commerce
408 kits
Distribution
US Nationwide distribution in the states of AL, GA, MA, NJ, and PA.
Product codes and lots
(1) REF CDS840132O - Lot number 24BBF701, exp. 10/31/2024, UDI-DI each 10195327245276, UDI-DI case 40195327245277; (2) REF DYNJ903016G - Lot numbers 24DBP801, exp. 8/31/2025; and 24CBJ749, exp. 11/30/2024, UDI-DI each - 10195327657154, UDI-DI case - 40195327657155.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0532-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0532-2025Class IIOngoingVoluntary: Firm initiated
Z-0533-2025Class IIOngoingVoluntary: Firm initiated
Z-0534-2025Class IIOngoingVoluntary: Firm initiated